New study aims to keep women with HIV on track for cervical cancer treatment

NCT ID NCT06182241

Ongoing Knowledge-focused Sponsor: Boston University Charles River Campus Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 4 times

Summary

This study in South Africa works with women who have HIV and abnormal Pap results to find out why some don't follow up for cervical cancer care. Researchers will interview patients and providers, then create a short counseling and navigation program. They will test if the program is practical and acceptable in a small pilot study with 60 women.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (counseling and navigation)
What this could lead to: If successful, this could lead to a practical program that helps women with HIV complete cervical cancer treatment, improving survival rates.
What could go wrong: This is a small, early-stage pilot study (80 participants) testing feasibility, not effectiveness. The intervention may not work in larger, diverse populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS cervical cancer HIV infectious disease Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER HIV

Contacts and locations

Locations

Boston University

Boston, Massachusetts, 02215, United States
Massachusetts General Hospital

Boston, Massachusetts, 02114, United States
MatCH Research Unit (MRU), a Division of the Wits Health Consortium, University of Witwatersrand

Durban, KwaZulu-Natal, 4000, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.